Double duct sign is an anatomical sign of combined dilatation of common bile duct and pancreatic duct. It is observed on imaging during endoscopic retrograde cholangio-pancreatography, magnetic resonance cholangio-pancreatography, computed tomography and ultrasound. The sign in a jaundiced patient is highly diagnostic of pancreatic carcinoma.
A 65-year-old male patient presented with progressive jaundice associated with pruritus of 2 months duration. His liver function tests showed direct bilirubinemia of 35 mg/dl, raised alkaline phosphatase of 1059 U/L, serum aspartate aminotransferase was 68 U/L, and serum alanine aminotransferase was 72 U/L. His ultrasound abdomen revealed dilated common bile duct (CBD) till its lower end with dilated intrahepatic biliary radicles. The computed tomography (CT) scan showed classical double duct sign with a periampullary mass [ Figure 1 ]. Side viewing endoscopy shows localized ulcerated ampulla [ Figure 2 ]. A biopsy from the growth was positive for adenocarcinoma. He underwent an endoscopic retrograde cholangiopancreatography (ERCP) for biliary system drainage. Stent was placed in the CBD to drain biliary system. He underwent pancreaticoduodenectomy (Whipple's) procedure.
Freeny et al. coined the term "double duct sign" for the first time in 1976 immediately after the clinical use of ERCP. [1] It is a combined dilatation of CBD and pancreatic duct. This anatomical sign is observed on modalities such as magnetic resonance cholangiopancreatography, CT, ultrasonography in addition to ERCP. [2] The two most common causes of the double-duct sign are carcinoma of the head of pancreas and carcinoma of the ampulla of Vater. Rarely, impacted gall stone in the distal duct, chronic pancreatitis, and ampullary cancer. [4] In patients without jaundice, pancreas cancer was only seen in 6% of patients with a double duct sign. [5] Financial support and sponsorship Nil.
Conflicts of interest
There are no conflicts of interest. stenosis has been documented as the cause of this sign. [3] The sign in the presence of jaundice is highly diagnostic of pancreatic carcinoma. In selected patients with an increased likelihood of pancreas cancer, based on the presence of jaundice or observed pancreatic mass on CT-scan, up to 85% of patients did indeed have a pancreas 
